Epitope as prologue

How Hummingbird develops antibodies against epitopes in natural conformation

Most antibody platforms target specific antigens, but offer little control over the exact binding location on the target or how the antibody affects activity. Hummingbird Bioscience Pte. Ltd. has developed a system for pinpointing the binding epitope and selecting antibodies that bind it in its natural configuration.

Hummingbird CEO Piers Ingram told BioCentury most companies begin with screening by peptide immunization against a target antigen to raise specific antibodies, or use

Read the full 702 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE